Stoke Therapeutics (STOK) PT Lowered to $58 at Canaccord
(Updated - August 4, 2026 6:57 AM EDT)
Canaccord analyst Sumant Kulkami lowered the price target on Stoke Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Canaccord analyst Sumant Kulkami lowered the price target on Stoke Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
